Today, leading Belgian newspaper De Tijd published an Op-ed co-signed by several BSP signatories on the potential and future of Belgian and EU biotech.
The Belgian biotech sector is world class in terms of innovation and R&D and a key pillar of the economy. The authors argue that biotech in Belgium has considerable potential, especially in terms of access and commercialization.
The potential of Europe in the biotech domain is also undeniable. In order to stay competitive and guarantee European patients have access to lifechanging medicines, a favourable environment and common approach is needed.
You can find the full Op-ed here and feel free to share our posts on LinkedIn and Twitter!